Evaluation of clinical criteria for diagnosis of bullous pemphigoid

Archives of Dermatology

Volumn 134, Issue 9, 1998, Pages 1075-1080

  Vaillant, Loïc ^a   Bernard, Philippe ^b   Joly, Pascal ^c   Prost, Catherine ^d   Labeille, Bruno ^f   Bedane, Christophe ^b   Arbeille, Brigitte ^g   Thomine, Elisabeth ^c   Bertrand, Philippe ^g   Lok, Catherine ^f   Roujeau, Jean Claude ^e  

^a SERVICE DE DERMATOLOGIE   (France)

^b DUPUYTREN UNIVERSITY HOSPITAL   (France)

^c HÔPITAL CHARLES NICOLLE   (France)

^d SAINT LOUIS HOSPITAL   (France)

^e HENRI MONDOR HOSPITAL   (France)

^f AMIENS UNIVERSITY HOSPITAL   (France)

^g CHU BRETONNEAU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; EPIDERMOLYSIS BULLOSA ACQUISITA; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; LUPUS ERYTHEMATOSUS; MAJOR CLINICAL STUDY; MALE; PEMPHIGOID; PRIORITY JOURNAL; SKIN BIOPSY;

AGED; FEMALE; HUMANS; MALE; MULTIVARIATE ANALYSIS; PEMPHIGOID, BULLOUS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 0031681385     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.134.9.1075     Document Type: Article

References (44)

1. Liu Z, Diaz LA, Troy JL, et al. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid using antibodies generated against the hemidemosomal antigen BP 180. J Clin Invest 1993;92:2480-2488.
2. Gammon WR, Merritt CC, Lewis DM, Sams WR, Carlo JR. An in vitro model of immune complex-mediated basement membrane zone separation caused by antibodies leukocytes and complement. J Invest Dermatol. 1982;78:285-290.
3. Mueller S, Klaus-Kovtun V, Stanley JR. A 230 kD basic protein is the major bullous pemphigoid antigen. J Invest Dermatol. 1989;92:33-38.
4. Bernard P. Recent advances on the 180-kDa epidermal antigen in autoimmune subepidermal skin diseases. Springer Semin Immunopathol. 1992;13:401-412.
5. Stanley JR, Tanaka T, Mueller S, Klaus-Kovtun V, Roop D. Isolation of complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies. J Clin Invest. 1988;82:1864-1870.
6. Morrisson LH, Labib RS, Zone JJ, Diaz LA, Anhalt GS. Herpes gestationis recognize a 180 kD human epidermal antigen. J Clin Invest. 1988;81:2023-2026.
7. Gammon WR, Murrell DF, Jenison MW, et al. Autoantibodies to type VII collagen recognize epitopes in a fibronectin-like region of the non-collagenous (NC1) domain. J Invest Dermatol. 1993;100:618-622.
8. Gammon WR, Briggaman RA. Bullous SLE: a phenotypically distinctive but immunologically heterogeneous bullous disorder. J Invest Dermatol. 1993;100: 285-345.
9. Bernard P, Prost C, Durepaire N, Basset-Seguin N, Didierjean L, Saurat JM. The major cicatricial pemphigoid antigen is a 180 kD protein which shows immunologic cross-reactivities with the bullous pemphigoid antigen. J Invest Dermatol. 1992;99:174-179.
10. Bernard P, Prost C, Lecerf V, et al. Studies of cicatricial pemphigoid autoantibodies using direct immunoelectron microscopy and immunoblot analysis. J Invest Dermatol. 1990;94:630-635.
11. Domloge-Hultsch D, Gammon WR, Briggaman RA, Gil SG, Carter WG, Yancey KB. Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired and an inherited subepidermal blistering skin disease. J Clin Invest. 1992; 90:1628-1633.
12. Pye RJ. Bullous eruption. In: Rook A, Wilkinsow DS, Ebling FJ, eds. Textbook of Dermatology. 5th ed. Oxford, England: Blackwell Scientific Publications; 1992: 1647-1665.
13. Yancey KB. From bedside to bench and back: the diagnosis and biology of bullous diseases. Arch Dermatol. 1994;130:983-987.
14. Bedane C, Prost C, Bernard P, Catanzano G, Bonnetblanc JM. Dubertret L Cicatricial pemphigoid antigen differs from bullous pemphigoid antigen by its exclusive extracellular localization: a study by indirect immunoelectron microscopy. J Invest Dermatol. 1991;97:3-9.
15. Bernard P, Vaillant L, Labeille B, et al, and the Bullous Diseases French Study Group. Incidence and distribution of subepidermal auto-immune bullous skin diseases in three French regions. Arch Dermatol. 1995;131:48-52.
16. Prost C, Labeille B, Chaussade V, Guillaume JC, Martin N, Dubertret L. Immunoelectron microscopy in subepidermal auto-immune bullous disease: a prospective study of IgG and C3 bound in vivo in 32 patients. J Invest Dermatol. 1987;89:567-573.
17. Prost C, Dubertret L, Fosse M, Wechsler J, Touraine R. A routine immunoelectron microscopic technique for localizing an autoantibody on epidermal basement membrane. Br J Dermatol. 1984;110:1-7.
18. Roger D, Vaillant L, Fignon A, et al. Specific pruritic diseases of pregnancy: a prospective study of 3192 pregnant women. Arch Dermatol. 1994;130: 734-739.
19. Pehamberger H, Koward K, Holubar K. Circulating IgA antibasement membrane antibodies in linear dermatitis herpetiformis immunofluorescence and immunoelectron microscopic studies. J Invest Dermatol. 1977;69:490-493.
20. Chorzelski TP, Jablowska S. Linear IgA dermatosis of childhood. Br J Dermatol. 1979;10:535-542.
21. Leonard JN, Haffenden GP, Ring NP, et al. Linear IgA disease in adults. Br J Dermatol. 1982;107:301-316.
22. Roenigk HH, Ryan JG, Bergfeld WF. Epidermolysis bullous acquisita: report of 3 cases and review of all published cases. Arch Dermatol. 1977;113:1-10.
23. Bhogal BS, Black MM. Diagnosis, diagnostic and research techniques. In: Wojnarowska F, Briggaman RA, eds. Management of Blistering Diseases. London, England: Chapman & Hall; 1990:15-34.
24. Joly P, Gilbert D, Thomine E, et al. Relationship between the in vivo localization and the immunoblotting pattern of anti-basement membrane zone antibodies in patients with bullous pemphigoid. Arch Dermatol. 1997;133:719-724.
25. Gohestani R, Kanitakis J, Nicolas JF, Cozzani E, Claudy A. Comparative sensitivity indirect immunofluorescence to immunoblot assay for the detection of circulating antibodies to bullous pemphigoid antigens 1 and 2. Br J Dermatol. 1996; 135:74-79.
26. Fine JD, Neises GR, Katz SI. Immunofluorescence and immunoelectron miscropic studies in cicatricial pemphigoid. J Invest Dermatol. 1984;82:39-43.
27. Machado P, Michalaki H, Roche P, Gaucherand M, Thivolet J, Nicolas JF. Serological diagnosis of bullous pemphigoid comparison of the sensitivity of indirect immunofluorescence on salt-split skin to immunoblotting. Br J Dermatol. 1992;126:236-241.
28. Bernard P, Didierjean L, Denis F, Saurat JH, Bonnetblanc JM. Heterogenous bullous pemphigoid antibodies: detection and characterization by immunoblotting when absent by indirect immunofluorescence. J Invest Dermatol. 1989;92:171-174.
29. Woodley DT, Briggaman RA, O'Keefe EJ, Inman AO, Queen LL, Gammon WR. Identification of the skin in basement membrane autoantigen in epidermolysis bullosa acquisita. N Engl J Med. 1984;310:1007-1013.
30. Rieckoff-Cantoni L, Bernard P, Didierjean L, Imhof K, Kinloch de loes S, Saurat JH. Frequency of bullous pemphigoid-like antibodies as detected by Western blotting in pruritic dermatoses. Arch Dermatol. 1992;128:791-794.
31. Kelly SE, Wojnarowska F. The use of chemically split tissue in the detection of circulating anti-basement membrane zone antibodies in bullous pemphigoid and cicatricial pemphigoid. Br J Dermatol. 1988;118:31-40.
32. Stanley JR, Hawley-Nelson P, Yuspa SH. Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamous epithelia. Cell. 1981;24:897-903.
33. Stanley JR, Woodley DT, Katz SI. Identification and partial characterization of pemphigoid antigen extracted from normal human skin. J Invest Dermatol. 1984; 82:108.
34. Meyer LJ, Taylor TB, Kadunce DP, Zone JJ. Two groups of bullous pemphigoid antigens are identified by affinity-purified antibodies. J Invest Dermatol. 1990; 94:611-616.
35. Sarret Y, Reano A, Nicolas JF, Su H, Thivolet J. Bullous pemphigoid and cicatricial pemphigoid: immunoblotting detection of involved autoantigens. Autoimmunity. 1989;2:145-153.
36. Chan LS, Hammerberg C, Cooper KD. Cicatricial pemphigoid: identification of two distinct sets of epidermal antigens by IgA and IgG class circulating autoantibodies. Arch Dermatol. 1990;126:1466-1468.
37. Diaz LA, Ratrie H, Saunders WM, et al. Isolation of a human epidermal cDNA corresponding to the 180kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera: immunolocalization of this protein to the hemidesmosome. J Clin Invest. 1990;86:1088-1094.
38. Anhalt GJ, Morrison L. Pemphigoid: bullous, gestational and cicatricial. In: Provost TT, Weston WL, eds. Bullous Diseases. St Louis, Mo: CV Mosby Co; 1993: 63-113.
39. Labib RS, Anhalt GJ, Patel HP. Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J Immunol. 1986;136:1231-1235.
40. Prost C. Pemphigoide bulleuse et épidermolyse bulleuse acquise: comment et pourquoi les différencier? Objectif Peau. 1993;2:6-11.
41. Karpouzis A, Prost C, Cordoliani F, Viguier D, Blum L, Puissant A. Epidermolyse bulleuse acquise ocalisée: un cas avec atteinte du cuirchevelu en immunomicroscopie électronique. Ann Dermatol Venereol. 1993;120:464-468.
42. Gammon WR, Kowalewski C, Chorzelski TP, et al. Direct immunofluorescence studies of sodium chloride-separated skin in the differential diagnosis of bullous pemphigoid and epidermolysisbullosaacquisita. J Am Acad Dermatol. 1990;22:664-670.
43. Gammon WR, Briggaman RA, Inman AO, Queen LL, Wheeler LE. Differentiating antilamina lucida and antisublamina densa antiBMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin. J Invest Dermatol. 1984;82:139-144.
44. Kirtschig G, Wojnarowska F. Auto-immune blistering diseases: an update of diagnostic methods and investigations. Clin Exp Dermatol. 1994;19:97-112.